Diabetes Australia and Blue Banner Pickles team up to fight diabetes 24 November 2021 Diabetes Australia today announced a new charitable partnership with Blue Banner Pickles to raise funds for the Diabetes Australia Research Program. Blue Banner Pickles is donating 10c from every jar sold of its No Added Sugar Pickled Onions to Diabetes Australia. This will support research projects into the prevention, management, and possible cure of diabetes. Blue Banner Pickles Chairman, Dan Presser, said the company was proud to support the Diabetes Australia Research Program. “Buying Blue Banner No Added Sugar Pickled Onions will help to find a cure for diabetes. For every jar purchased, we will donate 10c to Diabetes Australia to support world-class research projects,” Dan said. Dan and his son, who has type 1 diabetes, came up with the idea of a no added sugar version so he could continue to enjoy pickled onions. Recently launched in Tasmania, Blue Banner No Added Sugar Pickled Onions is available in all Woolworths stores, Hill St Grocer Stores and selected independent supermarkets such as Salamanca Fresh and IGA. Blue Banner Pickles plans to roll out No Added Sugar Pickled Onions to other states and supermarket chains in 2022, so check local independent retailers and, if they don’t stock it, ask them to order it in. Blue Banner No Added Sugar Pickled Onions’ secret recipe uses onions grown in Tasmania and is gluten free. Perfect as part of a summer grazing board or cheese platter, they’re also a tasty snack by themselves. Diabetes Australia’s logo features on the label of Blue Banner No Added Sugar Pickled Onions, recognising Blue Banner Pickles’ support of the Diabetes Australia Research Program. Every year Diabetes Australia invests more than $3.5 million into cutting edge diabetes research to support and improve the lives of people with diabetes. Important partnerships like this bring us closer to finding a cure for diabetes, and funds research into life-changing new treatments and ways to prevent the serious complications.
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
News 20 July 2026 Response to media reports from 60 Minutes, The Sydney Morning Herald, and The Age regarding regulation of diabetes technologies The safety of people living with diabetes must always come first. For many Australians, technologies such as insulin pumps and continuous glucose monitors are essential tools that help prevent dangerous high and low blood glucose levels, reduce the daily burden of living with diabetes and improve long-term health outcomes. For some individuals they can be life-changing or even life-saving. Continue Reading
Media releases 8 July 2026 Territory-led digital health innovation receives boost from national partnership A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from Diabetes Australia and Lilly Australia, in partnership with Menzies School of Health Research (Menzies). Continue Reading
